Corient Private Wealth LLC Raises Stock Holdings in Sotera Health Company $SHC

Corient Private Wealth LLC raised its stake in shares of Sotera Health Company (NASDAQ:SHC) by 217.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,342 shares of the company’s stock after acquiring an additional 30,373 shares during the period. Corient Private Wealth LLC’s holdings in Sotera Health were worth $773,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in SHC. Empowered Funds LLC increased its holdings in Sotera Health by 11.1% during the 1st quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Sotera Health by 14.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after acquiring an additional 43,471 shares in the last quarter. Acadian Asset Management LLC increased its position in shares of Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares during the last quarter. Creative Planning increased its position in shares of Sotera Health by 15.3% in the 2nd quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after purchasing an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Sotera Health by 4.2% in the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock valued at $3,549,000 after purchasing an additional 12,758 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Barclays increased their price target on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price objective for the company. UBS Group set a $19.00 target price on shares of Sotera Health in a report on Wednesday, June 24th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Finally, Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.25.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 15.36% of the stock is owned by insiders.

Sotera Health Stock Performance

NASDAQ SHC opened at $17.93 on Friday. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health Company has a 1-year low of $10.94 and a 1-year high of $19.85. The firm has a market capitalization of $5.11 billion, a P/E ratio of 43.73 and a beta of 1.76. The business’s 50-day simple moving average is $15.97 and its 200-day simple moving average is $16.35.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities analysts predict that Sotera Health Company will post 0.88 EPS for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.